Qiagen Stock
Qiagen Stock price
Key metrics
| Market capitalization | €8.27b |
| Enterprise Value | €8.50b |
| P/E (TTM) P/E ratio | 112.63 |
| EV/FCF (TTM) EV/FCF | 17.91 |
| EV/Sales (TTM) EV/Sales | 4.65 |
| P/S ratio (TTM) P/S ratio | 4.52 |
| P/B ratio (TTM) P/B ratio | 2.38 |
| Dividend yield | 3.30% |
| Last dividend (FY24) | €1.25 |
Create a Free Account to create an Qiagen alert.
Set up alerts on Stock Price, Dividend Yield, Valuation (e.g. P/E or EV/Sales) or Strategy Scores and sit back and relax.
Qiagen Stock Analysis
Analyst Opinions
21 Analysts have issued a Qiagen forecast:
Analyst Opinions
21 Analysts have issued a Qiagen forecast:
Financial data from Qiagen
| Dec '24 | |
| Current assets | 1,893 1,893 |
| Fixed assets | 3,602 3,602 |
| Total Assets | 5,495 5,495 |
| Dec '24 | |
| Equity | 3,445 3,445 |
| Debt capital | 2,050 2,050 |
| Total Capital | 5,495 5,495 |
In millions EUR.
Don't miss a Thing! We will send you all news about Qiagen directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Company Profile
QIAGEN NV is a holding company, which engages in the provision of sample and assay technology to transform biological samples into valuable molecular insights. It offers bioinformatics, molecular diagnostics, next-gen sequencing, and genomic services. The company was founded by Detlev H. Riesner and Metin Colpan on April 29, 1996 and is headquartered in Venlo, the Netherlands.
| Head office | United States |
| CEO | Thierry Bernard |
| Founded | 1996 |
| Website | www.qiagen.com |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
